Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CEVI.STthis companyCellaVision AB (publ)	SEK 201.50	24.49×	4.22×	4.94×	15.12×	-41.1%	68.5%	26.6%	20.2%	17.2%	16.0%	4.8%	0.03×	-0.69×	18.86×	3.98×	1.6%	5	12.04	4	A-
BOUL.STBoule Diagnostics AB	SEK 1.22	-49.1×	1.11×	0.38×	16.9×	-8578.3%	43.7%	0.9%	-0.8%	-2.3%	-0.7%	-2.2%	1.34×	8.83×	0.28×	1.09×	0.0%	3	0.3	2	C
DVYSR.STDevyser Diagnostics AB (publ)	SEK 64.10	-223.92×	5.35×	7.56×	49.58×	-193.5%	80.6%	4.2%	-3.4%	-2.4%	2.6%	0.4%	0.15×	-0.68×	0.78×	2.88×	0.0%	7	6.42	2	C+
IDLDX.STIDL Diagnostics AB (publ)	SEK 0.32	-6.7×	0.55×	1.53×	-7.18×	-1307.2%	52.2%	-20.2%	-22.9%	-8.2%	-6.6%	-11.3%	0.09×	2.89×	-24.09×	3.21×	0.0%	3	0.24	4	A
IMMNOV.STImmunovia AB	SEK 0.03	-0.54×	1.21×	114.1×	-0.02×	293.5%	-11606.4%	-11606.4%	-21301.5%	-225.4%	-108.4%	-100.3%	0.01×	0.99×	-1.2×	5.12×	0.0%	1	-42.87	2	C+
Peer median	—	-27.9×	1.16×	4.55×	8.44×	-750.3%	47.9%	-9.6%	-13.1%	-5.3%	-3.7%	-6.7%	0.12×	1.94×	-0.46×	3.05×	0.0%	3	0.27	2	—